- Category
- Micro (2022-23)
- Udyam number
- UDYAM-GJ-01-0205894

Nyalkaran Pharma Private Limited
About Nyalkaran Pharma Private Limited
Data last updated:
Nyalkaran Pharma Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 September 2022.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24290GJ2022PTC135829.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Ashvinkumar Maganbhai Golaviya (Managing Director) and Jaykumar Vadher.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Shop GF – 69 Shree Siddheshwar Harbour NH – 8 Waghodia Ring Road, Vadodara, Gujarat, India – 390001.
As per the financials filed for FY 2026, the company reported a revenue of ₹16.4 Lakh, a decline of 78% compared to the previous year. For the same year it recorded a net loss of ₹2.78 Cr and EBITDA of -₹2.24 Cr. Revenue has declined at a compounded annual rate (CAGR) of 57% over three years.
The company has about 2 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹15 Cr on record.
Nyalkaran Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0205894). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Nyalkaran Pharma
Contact details
Nyalkaran Pharma Private Limited's registered office is in Vadodara, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop GF – 69 Shree Siddheshwar Harbour NH – 8 Waghodia Ring Road, Vadodara, Gujarat, India – 390001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nyalkaran Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nyalkaran Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Nyalkaran Pharma Private Limited, buy the company report.
Financials of Nyalkaran Pharma Private Limited
FY 2026 filings availableNyalkaran Pharma Private Limited reported revenue of ₹16.4 Lakh (down 78% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 57% over three years, including a 78% fall in the latest year. EBITDA rose 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹16.4 Lakh | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹2.24 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹2.78 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Nyalkaran Pharma Private Limited, buy the company report.
Board of directors of Nyalkaran Pharma Private Limited
Nyalkaran Pharma has 6 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashvinkumar Maganbhai Golaviya Also directs: Nyalkaran Builders LLP, Nyalkaran Wellness Private Limited, Nyalkaran Retail Private Limited and 3 more | Managing Director | 29 Sep 2022 | 4 Years 1 Months | Current |
| Jaykumar Vadher | Director | 29 Sep 2022 | 4 Years 1 Months | Current |
| Rajanikant Kanubhai Bhalala | Director | 29 Sep 2022 | 4 Years 1 Months | Current |
| Alpeshkumar Rameshbhai Golaviya Also directs: Nyalkaran Builders LLP, Nyalkaran Wellness Private Limited, Nyalkaran Retail Private Limited and 3 more | Director | 29 Sep 2022 | 4 Years 1 Months | Current |
| Chirin Rameshbhai Golviya Also directs: Nyalkaran Builders LLP, Nyalkaran Wellness Private Limited, Nyalkaran Retail Private Limited and 3 more | Director | 29 Sep 2022 | 4 Years 1 Months | Current |
| Shailesh Pravinbhai Golviya Also directs: Nyalkaran Builders LLP, Nyalkaran Wellness Private Limited, Nyalkaran Retail Private Limited and 3 more | Director | 29 Sep 2022 | 4 Years 1 Months | Current |
Peer comparison
Nyalkaran Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Coind Anti-Pollution Systems Private Limited | ₹4.98 Cr (FY 2025) | -27.0% | Bangalore, Karnataka, India | |||
| Trendest Texkeys Private Limited | ₹4.98 Cr (FY 2025) | 57.0% | Machilipatnam, Andhra Pradesh, India | |||
| S Decor Impex Private Limited | ₹4.98 Cr (FY 2025) | 32.0% | Thane, Maharashtra, India | |||
| Refratech Minerals Private Limited | ₹4.97 Cr (FY 2025) | 41.0% | Jharsuguda, Odisha, India | |||
| VKS Ispat Udyog Private Limited | ₹4.97 Cr (FY 2025) | 23.0% | Durg, Chhattisgarh, India | |||
| Vardhman Vanijya Private Limited | ₹4.96 Cr (FY 2025) | -56.0% | Parganas North, West Bengal, India | |||
| Intra Medica Exim Private Limited | ₹4.96 Cr (FY 2025) | 33.0% | New Delhi, Delhi, India | |||
| Diosna Process Solutions Private Limited | ₹4.96 Cr (FY 2025) | -48.0% | Pune, Maharashtra, India | |||
| Hiluxe Gifts Private Limited | ₹4.96 Cr (FY 2025) | -46.0% | Mumbai, Maharashtra, India | |||
| D. R. Y. Pharmaceutical Private Limited | ₹4.95 Cr (FY 2024) | 1.0% | Delhi, India | |||
| Nyalkaran Pharma Private Limitedthis company | ₹16.4 Lakh (FY 2026) | -₹2.78 Cr | -78.0% | 2 | Vadodara, Gujarat, India |
To see the full peer comparison of Nyalkaran Pharma Private Limited, buy the company report.
Auditor
Nyalkaran Pharma Private Limited is audited by PRAVIN VORA & ASSOCIATES for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRAVIN VORA & ASSOCIATES | FY 2026 | 139599W |
Shareholding
The shareholding of Nyalkaran Pharma Private Limited is on record for 4 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Nyalkaran Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Apr 2023 | 100701607 | Others | ₹7.5 Cr | Open | |
| 28 Mar 2023 | 100697318 | Others | ₹7.5 Cr | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Nyalkaran Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nyalkaran Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nyalkaran Pharma Private Limited has a workforce of 2 employees on its EPFO records as of Mar 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 2 |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Nyalkaran Pharma Private Limited, buy the company report.
GST
No GST registration is on our record for Nyalkaran Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nyalkaran Pharma Private Limited has 7 board changes on record since 2022: 6 appointments and 1 cessation. The latest: Manoj Kumar Sharma ceased to be Director on 08 Jun 2024.
Frequently asked questions
Nyalkaran Pharma is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 September 2022 (4+ years old) and is registered under CIN U24290GJ2022PTC135829.
Nyalkaran Pharma has 6 current directors:
- Ashvinkumar Maganbhai Golaviya - Managing Director
- Jaykumar Vadher - Director
- Rajanikant Kanubhai Bhalala - Director
- Alpeshkumar Rameshbhai Golaviya - Director
- Chirin Rameshbhai Golviya - Director
- Shailesh Pravinbhai Golviya - Director
The latest financial statements of Nyalkaran Pharma on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Nyalkaran Pharma is U24290GJ2022PTC135829. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nyalkaran Pharma was incorporated on 29 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Nyalkaran Pharma by revenue are Coind Anti-Pollution Systems Private Limited, Trendest Texkeys Private Limited, S Decor Impex Private Limited, Refratech Minerals Private Limited, VKS Ispat Udyog Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Manoj Kumar Sharma ceased to be Director on 08 Jun 2024. Alpeshkumar Rameshbhai Golaviya was appointed as Director on 29 Sep 2022. Ashvinkumar Maganbhai Golaviya was appointed as Managing Director on 29 Sep 2022. Nyalkaran Pharma has 7 board changes on record in total.
Yes, Nyalkaran Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0205894).
The registered office of Nyalkaran Pharma is at Shop GF – 69 Shree Siddheshwar Harbour NH – 8 Waghodia Ring Road, Vadodara, Gujarat, India – 390001.
Nyalkaran Pharma operates in the pharma industry, in the drug formulation and development segment.
Nyalkaran Pharma has open charges of ₹15 Cr and no satisfied charges on record as per latest MCA filings.

